By Clara Holder
The CO-mmunity Corps blog series highlights the incredible work that members of the CO-mmunity Corps (Immunize Colorado’s AmeriCorps VISTA program) are doing across Colorado to build capacity for immunization programs.
My name is Clara, and I am one of the AmeriCorps VISTAs working on immunization education and outreach with Immunize Colorado. I work in Salida, Colorado at Chaffee County Public Health and spend my time engaging community partners and working on the COVID-19 response as well. I feel lucky to have been placed at a small LPHA (local public health agency) for all of the incredible experience that I’m getting, and am excited to share the research I’ve conducted over the past few months and the planned interventions I’ll be working on for the rest of my service year.
Across the U.S., vaccination rates and well-child visits are declining. According to data released by Centers for Disease Control and Prevention (CDC), there were 2.5 million fewer orders for routine vaccines (excluding flu vaccine) provided through the federally funded Vaccines for Children (VFC) program from mid-March to mid-April 2020 compared to the same period in 2019. And in Colorado, vaccinations have declined by an estimated 40% since the beginning of March.
By Stephanie Wasserman, MSPH
Executive Director, Immunize Colorado
The COVID-19 pandemic, which has caused over 2.6 million cases around the world and is growing each day, has shown us—in the most alarming way—the indisputable value of vaccines. And though we are at least a year away from having an effective COVID-19 vaccine, we do need to remember that we already have many available vaccines that are safe and highly effective against dozens of dangerous and sometimes deadly diseases that once ran rampant across the globe. Most of us have never seen the ravages of polio or measles, but these diseases can come roaring back if we do not stay vigilant about maintaining high vaccination rates.
By Aimee Pugh-Bernard, PhD
This post was originally published on April 4, 2013 and updated on March 17, 2020.
In the third installment of the Immunology 101 Series, Aimee explains the process of vaccine development. Vaccines undergo rigorous testing and must be proven extremely safe and effective before they are available for use in the general public.
As you may know from reading the first Immunology 101 Series post, vaccines train our immune systems to recognize and respond quickly to infection to keep us healthy. Reading the second Immunology 101 Series post, you learned that there are several different forms of vaccines, each created to produce the most effective vaccine possible based on the unique properties of each type of pathogen. In this post you will learn about the process of vaccine development. The process is lengthy and rigorous, just as it should be to prove that the end product is safe and effective! Read more